Synthetic Nanostructures Modulating Exosome Uptake via SR-B1 Binding
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for modulating or monitoring intercellular communication via vesicles, such as exosomes, face limitations in cargo loading variability and specificity for in vivo applications, particularly in targeting and inhibiting vesicle-mediated diseases like cancer and neurological disorders.
Innovation Solution
Development of synthetic nanostructures that associate with vesicles, specifically binding to receptors like SR-B1, forming a vesicle complex for therapeutic, diagnostic, or research purposes, which can be used to inhibit or modulate intercellular communication by affecting vesicle uptake or release.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current methods are used for exosome production and manipulation, then therapeutic cargo can be delivered systemically, but there is significant variability in cargo loading and limited applicability for in vivo applications
Solution Approach 1:
The patent introduces synthetic nanostructures as intermediaries that bind to cell surface receptors (such as SR-B1) to modulate exosome uptake. These nanostructures serve as mediators between therapeutic cargo and target cells, enabling controlled delivery while reducing variability in cargo loading and expanding in vivo applicability.
2Measurement precision
If exosomes are used for intercellular communication modulation, then targeted delivery to tumor and supporting cells is achieved, but the methods have significant limitations for in vivo applications
Solution Approach 1:
The patent employs parameter changes by modifying cell surface receptor expression levels (such as SR-B1) through synthetic nanostructure treatment. This allows precise control over exosome uptake parameters while maintaining targeting accuracy, thereby improving in vivo application feasibility without sacrificing measurement precision.
3Object-affected harmful factors
If lipid raft cholesterol content is modulated to inhibit exosome uptake, then downstream signaling events are inhibited, but the method lacks specificity for targeted therapy
Solution Approach 1:
The patent applies local quality by using synthetic nanostructures that specifically bind to certain cell surface receptors (such as SR-B1) in lipid rafts. This creates localized modulation of cholesterol content and exosome uptake at specific membrane domains, providing therapeutic specificity while effectively inhibiting harmful exosome-mediated communication.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanostructure vesicle complexes effectively inhibit exosome uptake by cells, providing a targeted approach for treating vesicle-mediated disorders and enabling diagnostic tracking of exosomes, thereby improving therapeutic delivery and diagnostic capabilities.
Implementation Method 1
a synthetic nanostructure, wherein the synthetic nanostructure is bound to the surface-bound receptor
Data Source
AI summary
Nanostructures, compositions and methods for treating vesicle-related or exosome-related conditions are provided. In some cases, the nanostructures and/or compositions may be used to treat cancers, neurological disorders, rheumatologic disorders, viral disorders or other diseases or conditions at least in part by regulating vesicle uptake. Methods of analyzing, imaging and modulating vesicles and cellular vesicles processes are also provided.